Kaempferol, which acted as a regulator of SIRT7, could enhance MCM6 Kcr level, alleviating tumour weight, especially combined with paclitaxel, which presents a potential chemotherapeutic target for BRCA therapy. This evidence concerns the gene CLEC4F and neoplasm.